<DOC>
	<DOCNO>NCT00623714</DOCNO>
	<brief_summary>The primary goal study implement innovative processing detection assay qualify induced sputum measurement marker allergen-induced airway inflammation . The result study intend form platform use clinical development novel asthma therapeutic .</brief_summary>
	<brief_title>Induced Sputum Study ( 0000-065 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patient history mild moderate persistent allergic asthma least 6 month typical symptom , include cough , wheeze , shortness breath , clinically stable history recent respiratory tract infection within 3 week start study Patient , aside history asthma , judge good health base medical history , physical examination , vital sign measurement , laboratory safety test . Patient able perform reproducible pulmonary function test . Patient allergic response house dust mite allergen , demonstrate positive early late phase response inhale allergen challenge ( defined bronchoconstrictive response ) Patient nonsmoker least 12 month . Patients must less equal 10 pack year smoke include . ( 10 pack year = one pack per day 10 year . ) Patients discontinue smoke least 10 month may enrol discretion investigator Patient willing avoid strenuous physical activity ( i.e. , strenuous unaccustomed weight lifting , run , bicycling , etc . ) 72 hour prior visit laboratory safety test obtain 48 hour prior allergen challenge Patient history illness , opinion study investigator , might confound result study pose additional risk patient participation study Patient take oral corticosteroid within 8 week inhale corticosteroids/nasal corticosteroid within 4 week screen and/or study Patient history stroke , chronic seizure , major neurological disorder Patient history clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory ( asthma ) , genitourinary abnormality disease , history neoplastic disease Patient unable refrain anticipates use medication one permit study , include prescription nonprescription drug herbal remedy prior administration initial dose study drug , throughout study ( include washout interval treatment period ) , poststudy visit Patient consume excessive amount alcohol , define great 3 glass alcoholic beverage per day &gt; 21 drink equivalent per week . Patient consumes excessive amount , define great 6 serving coffee , tea , cola , caffeinated beverage per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>